Malda J, van Blitterswijk C A, Grojec M, Martens D E, Tramper J, Riesle J
Cartilage Tissue Engineering Group, IsoTis, Bilthoven, The Netherlands.
Tissue Eng. 2003 Oct;9(5):939-48. doi: 10.1089/107632703322495583.
Functional cartilage implants for orthopedic surgery or in vitro tissue evaluation can be created from expanded chondrocytes and biodegradable scaffolds. Expansion of chondrocytes in two-dimensional culture systems results in their dedifferentiation. The hallmark of this process is the switch of collagen synthesis from type II to type I. The aim of this study was to evaluate the postexpansion chondrogenic potential of microcarrier-expanded bovine articular chondrocytes in pellet cultures. A selection of microcarriers was screened for initial attachment of chondrocytes. On the basis of those results and additional selection criteria related to clinical application, Cytodex-1 microcarriers were selected for further investigation. Comparable doubling times were obtained in T-flask and microcarrier cultures. During propagation on Cytodex-1 microcarriers, cells acquired a spherical-like morphology and the presence of collagen type II was detected. Both observations are indicative of a differentiated chondrocyte. Pellet cultures of microcarrier-expanded cells showed cartilage-like morphology and staining for proteoglycans and collagen type II after 14 days. In contrast, pellets of T-flask-expanded cells had a fibrous appearance and showed abundant staining only for collagen type I. Therefore, culture of chondrocytes on microcarriers may offer useful and cost-effective cell expansion opportunities in the field of cartilage tissue engineering.
用于骨科手术或体外组织评估的功能性软骨植入物可由扩增的软骨细胞和可生物降解支架制成。在二维培养系统中扩增软骨细胞会导致其去分化。这一过程的标志是胶原蛋白合成从II型转变为I型。本研究的目的是评估微载体扩增的牛关节软骨细胞在微团培养中的扩增后软骨形成潜力。筛选了一系列微载体用于软骨细胞的初始附着。基于这些结果以及与临床应用相关的其他选择标准,选择Cytodex-1微载体进行进一步研究。在T型烧瓶和微载体培养中获得了相当的倍增时间。在Cytodex-1微载体上增殖期间,细胞获得了球形形态,并检测到II型胶原蛋白的存在。这两个观察结果都表明细胞已分化为软骨细胞。微载体扩增细胞的微团培养在14天后显示出软骨样形态以及蛋白聚糖和II型胶原蛋白染色。相比之下,T型烧瓶扩增细胞的微团呈纤维状外观,仅显示I型胶原蛋白的丰富染色。因此,在微载体上培养软骨细胞可能在软骨组织工程领域提供有用且具有成本效益的细胞扩增机会。